RecruitingNCT00381121
University of Michigan "Nephrology Research BioBank"
Michigan Nephrology Research BioBank for Molecular Analysis of Renal Disease "Nephrology Research BioBank"
Sponsor
University of Michigan
Enrollment
420 participants
Start Date
Sep 1, 2006
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
Eligibility
Inclusion Criteria1
- Men, women and children undergoing kidney and/or pancreas biopsy at the University of Michigan
Exclusion Criteria1
- Individuals not willing to provide consent (for prospective biopsy)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00381121
Related Trials
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
NCT06926660153 locations
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
NCT07107945102 locations
A Prospecitve Multicenter, Observational Registry Study
NCT074815261 location
Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
NCT071694221 location
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
NCT072325371 location